( om/ target=blank>Genitope (cancer v...)Holiday Gift From Big Pharma

om/" target="blank">Genitope (cancer vaccines) are trading below the initial IPO price. As a group, the first seven are down 16 percent since their offerings.

Eyetech Pharmaceuticals was queued up for close to a $150 million IPO. Though Eyetech has a deal with Pfizer valued up to $745 million for its macular degeneration product......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 12/22/03


Page: 1 2
Related biology technology :

1. Unwrapping Political Perks for the Holidays
2. Holiday Tech Gizmos to Give and Get
3. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
4. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
5. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
6. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. The deconstruction of Big Pharma
9. First half of 2006 roundup: Big Pharma trumps biotech
10. Big Pharmas continued hunger and search for new products
11. Leading global Big Pharma companies of 2005